Integrated bioactivity assessment of Syzygium aromaticum bud extract from Sudan shows antimicrobial and antioxidant potential
Open Access
- 31 March 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
The escalating threat of antimicrobial resistance, coupled with the significant role of oxidative stress in chronic diseases, underscores the urgent need to identify novel multifunctional agents from natural sources to combat these issues. Clove (Syzygium aromaticum) is a well-known medicinal plant; however, comprehensive and standardized evaluations of its extracts are limited. This study provides an integrated pharmacological evaluation of an 80% ethanolic extract of clove (Syzygium aromaticum) buds. Phytochemical characterization revealed a rich composition, including high levels of total flavonoids (65.56 ± 0.05 mg QE/g) and phenolics (15.50 ± 0.02 mg GAE/g), along with alkaloids, tannins, and triterpenes content. The extract exhibited potent broad-spectrum antimicrobial activity against five standard strains (Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, and Candida albicans), with inhibition zones ranging from 12.0 to 16.3 mm at 100 mg/mL. The minimum inhibitory concentration (MIC) values ranged from 390 to 780 µg/mL, and the minimum bactericidal/fungicidal concentration (MBC/MFC) ratios (≤ 4) confirmed a cidal mechanism of action. Activity Index analysis further highlighted its relative efficacy, demonstrating superior activity to erythromycin against E. coli (AI = 1.03) and moderate activity against other pathogens. In the antioxidant assessment, the extract outperformed the standard propyl gallate, showing 91 ± 0.03% DPPH radical scavenging activity and a significantly lower IC₅₀ (6.09 µg/mL vs. 17.39 µg/mL). Preliminary toxicity screening using the brine shrimp lethality assay indicated a favorable safety margin, with an LD₅₀ of 882.97 µg/mL (classified as slightly toxic), which was markedly higher (less toxic) than that of the control drug etoposide (LD₅₀ = 7.46 µg/mL). These findings underscore the potential of clove extract as a multifunctional natural agent against microbial infections and oxidative stress, offering a promising alternative for combating antimicrobial resistance.Keywords
This publication has 43 references indexed in Scilit:
- Phytochemical analysis and evaluation of antimicrobial, antioxidant, and antidiabetic activities of essential oils from Moroccan medicinal plants: Mentha suaveolens, Lavandula stoechas, and Ammi visnagaBiomedicine & Pharmacotherapy, 2023
- Clove (Syzygium aromaticum) oleoresins2022
- From plants to antimicrobials: Natural products against bacterial membranesPhytotherapy Research, 2021
- Evaluation of the wound healing activity of the crude extract of root bark of Brucea antidysentrica, the leaves of Dodonaea angustifolia and Rhamnus prinoides in miceHeliyon, 2021
- Oxidative stress mitigation by antioxidants - An overview on their chemistry and influences on health statusEuropean Journal of Medicinal Chemistry, 2021
- Chemical composition, in-vitro antibacterial and antioxidant activities of Syzygium aromaticum essential oilJournal of Food Measurement and Characterization, 2020
- What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing M100, 29th EditionClinical Microbiology Newsletter, 2019
- Folin–Ciocalteu method for the measurement of total phenolic content and antioxidant capacity2017
- Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram-positive clinical pathogensComplementary Therapies in Clinical Practice, 2012
- Synergy research: Approaching a new generation of phytopharmaceuticalsFitoterapia, 2011